rhodamine 123 has been researched along with wortmannin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cappellini, A; Cocco, L; Conte, R; Evangelisti, C; Grafone, T; Martelli, AM; Martinelli, G; McCubrey, JA; Papa, V; Ricci, F; Tazzari, PL | 1 |
1 other study(ies) available for rhodamine 123 and wortmannin
| Article | Year |
|---|---|
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Androstadienes; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Fluorescent Dyes; Gene Expression Regulation, Leukemic; Genes, p53; Humans; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Leukocytes, Mononuclear; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neoplastic Stem Cells; Osteosarcoma; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Rhodamine 123; Tumor Suppressor Protein p53; Wortmannin | 2007 |